Neo-adjuvant chemo linked to above 95% overall survival in squamous cell cervical cancer

A review of patients with locally advanced bulky squamous cell carcinoma of the uterine cervix who underwent chemo-radiotherapy followed by surgery with pelvic lymphadenectomy showed that the technique was associated with a 5-year overall survival of 95.7%.